Cipla’s subsidiary to acquire US-based Avenue Therapeutics for $ 215 million
Drug major Cipla Tuesday said its subsidiary InvaGen Pharmaceuticals Inc has entered into definitive agreements to acquire US-based speciality business firm Avenue Therapeutics for up to USD 215 million (around…
Aurobindo Pharma shares fall 3% after Q2 earnings
New Delhi: Shares of Aurobindo Pharma Tuesday fell almost 3 per cent after the company reported 21.70 per cent dip in consolidated net profit for the quarter ended September 30,…
Lupin launches generic pneumonia drug in US
New Delhi: Drug firm Lupin said Monday it has launched the generic Atovaquone oral suspension, which is used for the prevention and treatment of pneumonia, in the US market. The…
Cipla gets USFDA nod for anti-viral eye infection drug for AIDS patients
Drug major Cipla Monday said it has received final approval from the US health regulator for Valganciclovir tablets, used in the treatment of viral eye infection in AIDS patients. Valganciclovir…
CIMS Medica presents 4th Grand edition of the “Nutrition & Wellness 2018”
CIMS Medica presents 4th Grand edition of the “Nutrition & Wellness 2018” Conference & Awards on 24th November 2018, Hotel Orchid Mumbai. ‘Nutrition and Wellness Awards 2018’ will recognize the…
IVA healthcare gave Diwali wishings to their IVA family members
IVA healthcare giving credits of their success to their dedicated team. IVA family wishing all of their associates and channel partners a very happy and prosperous Deepawali. IVA CEO “Manish…
Novartis division Sandoz recalls one lot of blood pressure drug
Novartis said on Thursday its Sandoz division was recalling one lot of losartan tablets after finding traces of a probable carcinogen in the blood pressure drug. The drug is made…
Torrent Pharma Q2 net profit dips 12 pc to Rs 179 crore
New Delhi: Drug firm Torrent Pharmaceuticals has reported a 12.25 per cent dip in its consolidated net profit to Rs 179 crore for the quarter ended September 2018 due to…
Roche’s Schwan says new drugs will replace lost sales – NZZ am Sonntag
Roche Chief Executive Severin Schwan said new drugs the pharma company is developing will replace the roughly 10 billion Swiss francs ($9.97 billion) lost from old cancer drugs, the executive…
HC impleads online medicine traders in plea seeking ban on e-pharmacies
Chennai: The Madras High Court Friday allowed firms involved in online sale of medicines to be impleaded in a petition seeking a ban on their business. Justice R Mahadevan, who…
